Search Results - "Inamdar, Rubina"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Effectiveness of Population Health Management Using the Propeller Health Asthma Platform: A Randomized Clinical Trial by Merchant, Rajan K., MD, Inamdar, Rubina, MD, Quade, Robert C., PhD

    “…Background Telehealth strategies for asthma have focused primarily on adherence to controller medications. Telemonitoring of short-acting β-agonist (SABA)…”
    Get full text
    Journal Article
  2. 2

    Efficacy of Vitamin D3 versus Vitamin D2 in deficient and insufficient patients: An open-label, randomized controlled trial by Nasim, Bina, Al Sughaiyer, Hana, Abdul Rahman, Samia, B. Inamdar, Rubina, Chakaki, Razan, Abuhatab, Suha

    “…Background: Vitamin D deficiency is very common worldwide but highly prevalent in the Gulf region. The clinical manifestations of Vitamin D deficiency vary…”
    Get full text
    Journal Article
  3. 3

    Glatiramer acetate: successful desensitization for treatment of multiple sclerosis by Bains, Sonia N., MD, Hsieh, Fred H., MD, Rensel, Mary R., MD, Radojicic, Cristine, MD, Katz, Hary T., MD, Inamdar, S. Rubina, MD, Lang, David M., MD

    Published in Annals of allergy, asthma, & immunology (01-04-2010)
    “…Background Glatiramer acetate is an immunomodulatory drug that is widely prescribed for the treatment of multiple sclerosis. It is frequently associated with…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Digital Health Intervention for Asthma: Patient-Reported Value and Usability by Merchant, Rajan, Inamdar, Rubina, Henderson, Kelly, Barrett, Meredith, Su, Jason G, Riley, Jesika, Van Sickle, David, Stempel, David

    Published in JMIR mHealth and uHealth (01-06-2018)
    “…Although digital health tools are increasingly recognized as effective in improving clinical outcomes such as asthma control and medication adherence, few…”
    Get full text
    Journal Article
  6. 6

    Approaches to maintenance dosing during oral immunotherapy by Inamdar, S. Rubina, Mandal, Binita

    “…Long term daily dosing for patients and families may be challenging due to food aversions, dosing protocols, and age of the patient. The few long term studies…”
    Get full text
    Journal Article